Kristín Ingólfsdóttir

Kristín Ingólfsdóttir is an Icelandic pharmaceutical scientist and former president and rector of the University of Iceland. She served two terms from 2005 to 2015 and was the first woman to hold office in the university's 100-year history. She succeeded Páll Skúlason.[1][2]

Prior to taking office Kristín was a professor at the university's Faculty of Pharmaceutical Sciences. Following her 10 years in office as rector she was visiting professor at Massachusetts Institute of Technology (MIT) from 2015 to 2017, based at edX and the MIT Media Lab. Kristín is currently chairman of the National University Hospital of Iceland (Icelandic: Landspítali) Advisory Board[3] and Vice President of the Board of Governors of the University of Luxembourg.[4]

She is chairman of the Board of Trustees of the Leifur Eiriksson Foundation, appointed by the Central Bank of Iceland and the University of Virginia.[5] Kristin sits on the boards of two Icelandic research-based startup companies, Atmonia and Akthelia and is a member of the International Scientific Committee at the University of Grenoble in France.[6] She is a board member of the European Women Rectors' Association (EWORA)[7] and the Committee of the Nordic Medical Research Councils (NOS-M).[8] From 2011 to 2015 Kristin served as an elected board member of the European University Association (EUA) and was a longstanding member of the Medicine Council of the Icelandic Medicines Agency.[7]

Education edit

Kristín studied at Reykjavik Junior College, then continued to study pharmaceutical sciences at the University of Iceland (BSc, 1978). She received her doctoral degree from King's College London (PhD, 1983),[1] in the field of pharmaceutical chemistry, focusing on natural products.[9]  Her PhD supervisor was Professor Peter J. Hylands. Her research has involved isolation and chemical identification of active pharmacological compounds from Icelandic lichens, mosses and marine organisms.[10][11][12][13][14] She has further written on the urgency of strategic reform in education to meet changing needs for working environments, society and individual well-being.[15][16]

References edit

  1. ^ a b "Háskóli Íslands |". www.hi.is. Retrieved 2019-08-12.
  2. ^ "Tímarit.is".
  3. ^ "Kristín Ingólfsdóttir skipuð formaður ráðgjafarnefndar Landspítala". Landspítali (in Icelandic). 22 July 2017. Retrieved 2019-08-12.
  4. ^ Luxembourg, Université du. "Composition du conseil de gouvernance". Université du Luxembourg. Retrieved 2019-08-12.
  5. ^ "Board Of Trustees". The Leifur Eiríksson Foundation. Retrieved 2019-08-12.
  6. ^ Vidron, Noemie. "Univ. Grenoble Alpes – Seconde visite des membres de l'International Scientific Committee de l'IDEX". Univ. Grenoble Alpes (in French). Retrieved 2019-08-12.
  7. ^ a b "Ewora Women Rectors Association | Kristín Ingólfsdóttir". www.ewora.org. Archived from the original on 2019-08-12. Retrieved 2019-08-12.
  8. ^ "Members | Nos M". nos-m.org. Archived from the original on 2019-08-12. Retrieved 2019-08-12.
  9. ^ Chemical and antimicrobial investigations on Icelandic lichens and mosses. Ph. D. thesis, University of London, 235 pp., 1983.
  10. ^ Ingolfsdottir K, Breu W, Huneck S, Gudjonsdottir GA, Wagner H. In vitro inhibition of 5-lipoxygenase by protolichesterinic acid from Cetraria islandica. Phytomedicine 1, 187 (1994).
  11. ^ Gissurarson SR, Sigurðsson SB, Wagner H, Ingolfsdottir K. Effect of lobaric acid on cysteinyl-leukotriene formation and contractile activity of guinea-pig taenia coli. Journal of Pharmacology and Experimental Therapeutics 280(2), 770 (1997).
  12. ^ Ingolfsdóttir K, Hjalmarsdottir MÁ, Guðjonsdottir GA, Brynjolfsdottir A, Sigurðsson A, Steingrimsson Ó. In vitro susceptibility of  Helicobacter pylori to protolichesterinic acid from Cetraria islandica. Antimicrobial Agents and Chemotherapy  41(1), 215 (1997).
  13. ^ Ingolfsdottir K, Gudmundsdottir GF, Ögmundsdottir HM, Paulus K, Haraldsdóttir S, Kristinsson H, Bauer R. Effects of tenuiorin and methyl orsellinate from Peltigera leucophlebia on 5-/15-lipoxygenases and proliferation of malignant cell lines in vitro. Phytomedicine  9 (7), 654 (2002).
  14. ^ Ingolfsdottir K. Molecules of interest : Usnic acid. Phytochemistry 61(7), 729 (2002).
  15. ^ Ingolfsdottir K. Impact of MOOCs and other forms of online education. Point of View. Proceedings of the Institute of Electrical and Electronics Engineers (IEEE), 102(11), 1639–1643 (2014). http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=6926925
  16. ^ Ingolfsdottir K. Winds of Change in Higher Education. Trends in Pharmacological Sciences, 37(12), 990-992 (2016). doi:10.1016/j.tips.2016.09.008
Academic offices
Preceded by Rector of the University of Iceland
2005–2015
Succeeded by